Home Health Fidson Plc to Build $100M Drug Plant in Nigeria, in Partnership with Chinese Firms
HealthNews

Fidson Plc to Build $100M Drug Plant in Nigeria, in Partnership with Chinese Firms

692

Fidson Healthcare Plc, Nigeria’s largest drugmaker, has announced a partnership with Chinese companies to build a $100 million pharmaceutical plant in Lagos. This collaboration involves Jiangsu Aidea Pharmaceutical Co., PharmaBlock Sciences Nanjing Inc., and the China-Africa Development Fund. The facility is expected to be completed in 30 months.

The new plant aims to boost Nigeria’s healthcare self-reliance, particularly in addressing the needs of HIV treatment. With around 2 million people living with HIV in the country, access to anti-retroviral drugs is crucial, Fidson said. Currently, Nigeria imports all its anti-retroviral medications, which limits availability. Also, this raises concerns due to economic challenges like inflation and energy shortages.

Recent exits of multinational drugmakers like GSK Plc and Sanofi SA have worsened medicine shortages. Fidson, which previously manufactured products for GSK, said it will be stepping in to fill this gap. The company has introduced over 16 new products since June 2023. Fidson expressed confidence in the partnership and stated that it will greatly improve the country’s pharmaceutical landscape.

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

AgricultureNews

Kenya Exports 50 Ayrshire Cows to Nigeria, Marking Milestone in Intra-African Trade

In a significant boost to East-West African trade relations, Kenya has airlifted...

News

Delayed Retirements: Tinubu Extends Customs Director General Tenure Past Lawful Limit

President Bola Tinubu has approved a one-year extension for the Comptroller-General of...

News

Is Nigeria’s Constitution Being Rewritten from Abroad? Spotlight on PLAC and MacArthur Funding

In a report in December 2024, the House of Representatives Press Corps...